Non-contact Imaging Device (Camera) Can Help Improve Treatment for Patients With Basal Cell Carcinoma.
18 Years
N/A
Both
Skin Cancer
Trial Information
Non-contact Imaging Device (Camera) Can Help Improve Treatment for Patients With Basal Cell Carcinoma.
The current standard of care for skin cancer is excision, curettage and electrodesiccation
and/or cryosurgery. These methods result in scarring, whereas PDT, on the other hand,
offers the potential for enhanced treatment with less scarring. In spite of this advantage
that PDT has over current techniques, it has still not achieved the consistent performance
required to gain clinical acceptance.
The researchers want to use an imaging system that can characterize the tissue and
photosensitizer optical properties and use that information to drive a treatment light
projection system that can spatially optimize the light irradiance for personalized
treatment, thus improving outcomes.
Inclusion Criteria:
- Age > 18 years
- Biopsy proven diagnosis of a basal cell carcinoma in a non-facial area
Exclusion Criteria:
- Age < 18 years
- Pregnancy
- Breast feeding.
- photosensitivity
Type of Study:
Interventional
Study Design:
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care
Outcome Measure:
To determine if non-contact optical imaging device called Modulated Imaging (MI), can help us customize PDT treatment for patients with skin cancer.
Outcome Time Frame:
4 weeks
Safety Issue:
Yes
Principal Investigator
Kristen M Kelly, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Beckman Laser Institute University of California Irvine
Authority:
United States: Institutional Review Board
Study ID:
LAMMP-NIH-
NCT ID:
NCT00784108
Start Date:
October 2008
Completion Date:
September 2012
Related Keywords:
- Skin Cancer
- Skin Neoplasms
Name | Location |
|---|---|
| Beckman Laser Institute Medical clinic | Irvine, California 92612 |
